Response to a combination of erlotinib and bevacizumab therapy after immune checkpoint inhibitor

• orcid.org/0000-0002-9262-0949

Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba, Japan

Search for more papers by this author

Division of Respiratory Medicine, Ryugasaki Saiseikai General Hospital, Japan

Search for more papers by this author

• orcid.org/0000-0002-5489-2062

Division of Respiratory Medicine, Hitachinaka Medical Center, University of Tsukuba, Japan

Search for more papers by this author

Corresponding Author

• hirosato@md.tsukuba.ac.jp

• orcid.org/0000-0002-1561-1723

Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba, Japan

Correspondence

Hiroaki Satoh, Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba, Japan.

Email: hirosato@md.tsukuba.ac.jp

Search for more papers by this author